• Gilead's filgotinib phase 3 hits primary endpoint but details dampen hopes

    10 days ago - By Fierce Biotech

    Gilead's filgotinib phase 3 hits primary endpoint but details dampen hopes ntaylor
    Thu, 05/21/2020 - 07:21
    Read more ...